Last reviewed · How we verify

NCT04356365

The Mental Health Status of the General Population During the COVID-19 Pandemic and Its Association With Adherence to Government-initiated Non-pharmacological Epidemiological Interventions (NPI's)

Completed Last updated 24 April 2020
What this trial tests

trial testing Cross-sectional study investigating the association of NPIs with mental health in Depression in 10,084 participants. Completed in 7 April 2020.

Timeline
31 March 2020
Primary endpoint
7 April 2020
7 April 2020

Quick facts

Lead sponsorUniversity of Oslo
StatusCompleted
Study typeOBSERVATIONAL
Enrollment10,084
Start date31 March 2020
Primary completion7 April 2020
Estimated completion7 April 2020
Sites1 location across Norway

Drugs / interventions tested

Conditions studied

Sponsor

University of Oslo

Who can join

18 and older, any sex, with Depression or Generalized Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study seeks to investigate the levels of common psychopathology symptoms (i.e., depression and generalized anxiety) in a general population during the strict social distancing government-initiated non-pharmacological interventions (NPI's) related to the COVID-19 pandemic. The study also seeks to examine the predictors of generalized anxiety and depressive symptoms, as well as predictors of adherence rates to government-initiated non-pharmacological epidemiological interventions (NPI's). The aim of the project is to: * Inform the policymakers, the general public, scientists, and health practitioners about the psychological associations of the COVID-19-related government-initiated measures. * Provide a foundation for policymakers and health-care professionals to employ interventions that protect the general public against possibly increased psychological stressors, suffering and dysfunction during society's handling of the pandemic. * Help policymakers better understand the associations of demographic variables and psychological symptoms with adherence, providing an initial understanding of adherence rates, which may be used to help society fight against the COVID-19-virus from an epidemiological perspective by promoting factors that increase adherence.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The mental health impact of non-pharmacological interventions aimed at impeding viral transmission during the COVID-19 pandemic in a general adult population and the factors associated with adherence to these mitigation strategies
    Ebrahimi OV, Hoffart A, Johnson SU. · · 2020 · DOI 10.31234/osf.io/kjzsp

Verify or expand the search:

Other recruiting trials for Depression

Currently open trials in the same condition.

Other University of Oslo trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04356365.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing